- Filed
- Oct 9, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Oct 8, 2025 | 25.03M sh |
| Shares Diluted restated | Q2 2025 · Jan 31, 2025 | 100.11M sh |
| Shares Diluted restated | Q2 2025 · Jan 31, 2025 | 100.11M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 100.11M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 100.11M sh |
| Operating Cash Flow restated | Q2 2025 · Jan 31, 2025 | $183.91K |
| Operating Cash Flow | Q2 2025 · Jan 31, 2024 | −$34.29K |
| Cash And Equivalents | Q2 2025 · Jan 31, 2025 | $35.56K |
| Cash And Equivalents | Q2 2025 · Jul 31, 2024 | $310.76K |
| Stockholders Equity | Q2 2025 · Jan 31, 2025 | −$3.05M |
| Stockholders Equity | Q2 2025 · Oct 31, 2024 | −$3.27M |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | −$3.35M |
| Stockholders Equity | Q2 2025 · Jan 31, 2024 | −$4.56M |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | −$4.42M |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | −$4.49M |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $5.03M |
| Current Liabilities | Q2 2025 · Jul 31, 2024 | $7.04M |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $5.03M |
| Total Liabilities | Q2 2025 · Jul 31, 2024 | $7.04M |
| Current Assets | Q2 2025 · Jan 31, 2025 | $1.77M |
| Current Assets | Q2 2025 · Jul 31, 2024 | $3.47M |
| Total Assets | Q2 2025 · Jan 31, 2025 | $1.99M |
| Total Assets | Q2 2025 · Jul 31, 2024 | $3.69M |
| Eps Diluted restated | Q2 2025 · Jan 31, 2025 | $0.00 |
| Eps Diluted restated | Q2 2025 · Jan 31, 2025 | $0.00 |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | $0.00 |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | $0.00 |
| Eps Basic restated | Q2 2025 · Jan 31, 2025 | $0.00 |
| Eps Basic restated | Q2 2025 · Jan 31, 2025 | $0.00 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | $0.00 |
| Eps Basic | Q2 2025 · Jan 31, 2024 | $0.00 |
| Sga Expense | Q2 2025 · Jan 31, 2025 | $201.19K |
| Sga Expense | Q2 2025 · Jan 31, 2025 | $366.76K |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $21.94K |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $42.13K |
| Net Income | Q2 2025 · Jan 31, 2025 | $144.02K |
| Net Income | Q2 2025 · Jan 31, 2025 | $271.28K |
| Net Income | Q2 2025 · Oct 31, 2024 | $127.27K |
| Net Income | Q2 2025 · Jan 31, 2024 | −$20K |
| Net Income | Q2 2025 · Jan 31, 2024 | −$45.45K |
| Net Income | Q2 2025 · Oct 31, 2023 | −$25.46K |
| Operating Income | Q2 2025 · Jan 31, 2025 | $176.85K |
| Operating Income | Q2 2025 · Jan 31, 2025 | $368.92K |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$15K |
| Operating Income | Q2 2025 · Jan 31, 2024 | −$35.2K |
| Revenue | Q2 2025 · Jan 31, 2025 | ¥63.5M |
| Revenue | Q2 2025 · Jan 31, 2025 | $8.9M |